- Home
- PAVS vs CNTX Comparison
PAVS vs CNTX Comparison
Compare PAVS & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CNTX
- Stock Information
- Founded
- PAVS 2004
- CNTX 2015
- Country
- PAVS United States
- CNTX United States
- Employees
- PAVS N/A
- CNTX N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- CNTX Health Care
- Exchange
- PAVS Nasdaq
- CNTX Nasdaq
- Market Cap
- PAVS 89.6M
- CNTX 78.0M
- IPO Year
- PAVS 2019
- CNTX 2021
- Fundamental
- Price
- PAVS $1.00
- CNTX $0.59
- Analyst Decision
- PAVS
- CNTX Strong Buy
- Analyst Count
- PAVS 0
- CNTX 4
- Target Price
- PAVS N/A
- CNTX $6.00
- AVG Volume (30 Days)
- PAVS 12.3K
- CNTX 167.4K
- Earning Date
- PAVS 01-01-0001
- CNTX 05-07-2025
- Dividend Yield
- PAVS N/A
- CNTX N/A
- EPS Growth
- PAVS N/A
- CNTX N/A
- EPS
- PAVS N/A
- CNTX N/A
- Revenue
- PAVS $6,613,273.00
- CNTX N/A
- Revenue This Year
- PAVS N/A
- CNTX N/A
- Revenue Next Year
- PAVS N/A
- CNTX N/A
- P/E Ratio
- PAVS N/A
- CNTX N/A
- Revenue Growth
- PAVS 2.50
- CNTX N/A
- 52 Week Low
- PAVS $0.32
- CNTX $0.49
- 52 Week High
- PAVS $1.50
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- PAVS 41.77
- CNTX 29.92
- Support Level
- PAVS $0.94
- CNTX $0.49
- Resistance Level
- PAVS $1.08
- CNTX $0.71
- Average True Range (ATR)
- PAVS 0.06
- CNTX 0.08
- MACD
- PAVS 0.01
- CNTX -0.02
- Stochastic Oscillator
- PAVS 55.50
- CNTX 27.22
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.